Delstrigo

Delstrigo is a combination medication containing Lamivudine, Doravirine, and Tenofovir Disoproxil, used for managing HIV infection. This oral medication is designed to help control the virus and improve quality of life.

Delstrigo is primarily used in the treatment of HIV infection. It works by combining three active ingredients to target the virus, helping to reduce its presence in the body. This medication is often prescribed as part of a comprehensive treatment plan to manage HIV and its symptoms.

Common effects of Delstrigo may include headaches, nausea, and fatigue. Some individuals might experience dizziness or changes in mood. It's important to discuss any persistent or severe effects with a healthcare provider.

Delstrigo should be handled with care, following the guidance of a healthcare professional. It is important to inform your healthcare provider about any other medications you are taking to avoid potential interactions. Regular monitoring may be required during treatment.

Delstrigo may interact with other medications, including certain antacids, antibiotics, and antifungal drugs. It is crucial to inform your healthcare provider about all medications you are taking to minimize the risk of interactions. Alcohol consumption should be discussed with a healthcare provider.